Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 14;109(7):2533-8.
doi: 10.1073/pnas.1121407109. Epub 2012 Jan 30.

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5

Affiliations

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5

Ute I Scholl et al. Proc Natl Acad Sci U S A. .

Abstract

We recently implicated two recurrent somatic mutations in an adrenal potassium channel, KCNJ5, as a cause of aldosterone-producing adrenal adenomas (APAs) and one inherited KCNJ5 mutation in a Mendelian form of early severe hypertension with massive adrenal hyperplasia. The mutations identified all altered the channel selectivity filter, producing increased Na(+) conductance and membrane depolarization, the signal for aldosterone production and proliferation of adrenal glomerulosa cells. We report herein members of four kindreds with early onset primary aldosteronism of unknown cause. Sequencing of KCNJ5 revealed that affected members of two kindreds had KCNJ5(G151R) mutations, identical to one of the prevalent recurrent mutations in APAs. These individuals had severe progressive aldosteronism and hyperplasia requiring bilateral adrenalectomy in childhood for blood pressure control. Affected members of the other two kindreds had KCNJ5(G151E) mutations, which are not seen in APAs. These subjects had easily controlled hypertension and no evidence of hyperplasia. Surprisingly, electrophysiology of channels expressed in 293T cells demonstrated that KCNJ5(G151E) was the more extreme mutation, producing a much larger Na(+) conductance than KCNJ5(G151R), resulting in rapid Na(+)-dependent cell lethality. We infer that this increased lethality limits adrenocortical cell mass and the severity of aldosteronism in vivo, accounting for the milder phenotype among these patients. These findings demonstrate striking variations in phenotypes and clinical outcome resulting from different mutations of the same amino acid in KCNJ5 and have implications for the diagnosis and pathogenesis of primary aldosteronism with and without adrenal hyperplasia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
KCNJ5 mutations in patients with early onset primary aldosteronism. (Left) Pedigrees are shown, with affected subjects shown as filled symbols and unaffected family members as open symbols; subjects are numbered as in Table 1. The index case is denoted with an arrow. (Right) Sanger DNA sequence traces and corresponding amino acids at KCNJ5 positions 150–152 of tested subjects are shown. In each case, a single-base pair substitution leads to a missense mutation: G151R in affected members of K767 and K409 and G151E in families 1486 and 124. The mutation in subject 409-1 is a de novo mutation.
Fig. 2.
Fig. 2.
Survival of 293T cells transfected with WT and mutant KCNJ5 channels. WT or mutant eGFP-tagged KCNJ5 was transfected into 293T cells, and the percentage of eGFP-positive cells was measured at indicated times by flow cytometry (20,000 events counted per data point). (A) Incubation in physiologic medium (Materials and Methods) shows lower percentage of cells expressing KCNJ5G151R than KCNJ5WT at 36 h (P = 0.003) and lower percentage of cells expressing KCNJ5G151E than either KCNJ5WT (P < 0.0001) or KCNJ5G151R (P = 0.003). (B) Reduction of extracellular Na+ by choline substitution significantly increased survival of cells expressing KCNJ5G151R and KCNJ5G151E at 24 and 36 h, with a more pronounced effect on the G151E mutant (for both mutant channels, P = 0.02 for low Na+ vs. normal medium at 24 h; P = 0.04 at 36 h).
Fig. 3.
Fig. 3.
KCNJ5G151E channels have higher Na+ permeability than KCNJ5G151R channels. Whole-cell currents of 293T cells transiently transfected with WT or mutant KCNJ5 channels were measured by using the patch-clamp technique and the voltage protocol indicated in A. Because incubation in solutions with physiological Na+ concentrations led to death of cells expressing KCNJ5G151E, an extracellular solution containing 40 mM NaCl, 100 mM KCl, and 2 mM MgCl2 (pH 7.4, adjusted with KOH) and an intracellular solution containing 140 mM KCl, 4 mM MgCl2, and 5 mM Hepes (pH 7.4, adjusted with KOH) was used (control). In Ba2+ conditions, 1 mM Ba2+ was added to the above extracellular medium. In Ba2+/choline conditions, choline was substituted for Na+ as described in Materials and Methods. Representative whole-cell recordings are shown in A, and IV curves are shown in B. In B, black, red, and green symbols denote control, Ba2+, and Ba2+/choline conditions, respectively. For better visibility, only one in two data points is plotted where curves overlap. Currents were negligible following transfection with empty vector (Fig. S3). Typical inwardly rectifying currents were observed for the WT channel; barium-sensitivity was abolished in the mutant channels. KCNJ5G151E showed larger currents than KCNJ5G151R, which were abolished by substitution of choline for Na+, indicating a predominant Na+ conductance. (C) Mean current amplitudes at −100 mV for WT and mutant channels using the solutions described in A. Net Na+ current is calculated by subtracting the current after choline substitution from the Ba2+ resistant current. Na+ current is significantly larger in the G151E mutant than in G151R mutant (P < 0.001). n ≥ 3 for each condition.

References

    1. Kearney PM, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217–223. - PubMed
    1. Chobanian AV, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572. - PubMed
    1. WHO . Global Health Risks - Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: WHO; 2009.
    1. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief. 2010;(48):1–8. - PubMed
    1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545–556. - PubMed

Publication types

Substances